Trial Search Results

The Impact of Pediatric Skin Disorders: The "Big" Study

This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Northwestern University

Collaborator: Immunex Corporation

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   - Subjects must be aged 8-17 years of age

   - Subject must be diagnosed with a chronic skin disease deemed to be severe enough
   and/or in a visible location that could be stigmatizing as determined by the study
   doctor

   - Subject and parent must both be English speaking with at least one parent/guardian who
   will complete the questionnaires

   - Subject and Parent/Guardian must be able to complete the relevant questionnaires

Exclusion Criteria:

   - Children under 8 years of age

   - Children with developmental delay and/or a behavioral disorder that would preclude
   participation in form completion

   - Children with a non-cutaneous disorder that is considered by the Study doctor to be
   stigmatizing

Ages Eligible for Study

8 Years - 17 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Pediatric Dermatology Study
650-723-0636
Recruiting